Do statins help decrease vein blood clot risk in women taking hormone therapy?

Statins have been studied for their potential role in reducing venous thromboembolism (VTE) risk in women using hormone therapy. In this episode, we examine the current evidence and how clot risk is assessed in Europe.

In this episode, we cover:

• What venous blood clots are (deep vein thrombosis and pulmonary embolism)

• How oestrogen-containing hormone therapy may increase clot risk

• What statins do (LDL reduction and anti-inflammatory effects)

• Research exploring statins and VTE risk modification

• Established clot prevention strategies

• Risk factors doctors screen for before prescribing hormone therapy

• When statins are clinically indicated — and when they are not

• Situations where prescription requests may be declined

Doctors assess personal and family clot history, BMI, smoking status, age, migraine with aura, cardiovascular profile, and current medications before prescribing hormone therapy or statins. Statins are not routinely prescribed solely to offset hormone-related clot risk without other indications.

Some patients require in-person evaluation or blood testing before treatment decisions are made.

This episode reflects how cardiovascular and hormonal risk is reviewed within European telemedicine at Mobi Doctor.

Read the full medical guide here:

https://www.mobidoctor.eu/blog/statins-help-decrease-vein-blood-clot-risk-in-women-taking-hormone-therapy